CEVR Fall 2025 Newsletter

From QALYs to Equal Value Life Years: Is Anyone Making the Shift?

New CEVR Study Examines Coverage Policies for Cell and Gene Therapies

David Strutton, PhD, to Join Tufts-CEVR as Senior Fellow